CD276 and cancer: Cancer stem cells (CSC) can upregulate immune checkpoint molecules like PD-L1, CTLA-4, B7-H3, and B7-H4, enabling them to evade immune surveillance more effectively (Mortezaee and Majidpoor, 2023).